Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 75007-501

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 75007-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ningbo Shuangcheng Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Bortezomib0010)

FDA Label Image

Image Description (Bortezomib008)

FDA Label Image

Image Description (Bortezomib009)

FDA Label Image

Image Description (Bortezomib02)

FDA Label Image

Image Description (Bortezomib03)

FDA Label Image

Image Description (Bortezomib04)

FDA Label Image

Image Description (Bortezomib05)

Image Description (Bortezomib05)
This text seems to be a statistical analysis related to the effectiveness of Bortezomib and Dexamethasone in patients over time. The data includes the number of patients remaining at specific time points and p-values from log-rank tests. It appears to be part of a study or research project evaluating the impact of these medications on patients.*
FDA Label Image

Image Description (Bortezomib06)

FDA Label Image

Image Description (Bortezomib07)

FDA Label Image

Image Description (Bortezomib01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.